Frederick W. Reimherr, MD

Types of Adult ADHD

March 17, 2020

Read the full study examining Adult ADHD types and symptoms not reflected in the DSM-5 or ICD-10 criteria.

Frederick W. Reimherr, Michael Roesler, Barrie K. Marchant, et al

Article

The Effect of Personality Disorder Symptoms on Response to Treatment With Methylphenidate Transdermal System in Adults With Attention-Deficit/Hyperactivity Disorder

October 11, 2012

This trial was designed to prospectively explore the relationship among personality disorder (PD) symptoms, attention-deficit/hyperactivity disorder (ADHD), and treatment response in a randomized, double-blind, crossover clinical trial of methylphenidate...

John L. Olsen, Frederick W. Reimherr, Barrie K. Marchant, et al

Original Research

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

February 22, 2011

James G. Barbee, Thomas R. Thompson, Nowal J. Jamhour, et al

Original Research

Gender Differences in 2 Clinical Trials of Adults With Attention-Deficit/Hyperactivity Disorder: A Retrospective Data Analysis

February 14, 2008

Reid J. Robison, Frederick W. Reimherr, Barrie K. Marchant, et al

Original Research

Addition of Atomoxetine for Depression Incompletely Responsive to Sertraline: A Randomized, Double-Blind, Placebo-Controlled Study

April 16, 2007

David Michelson, Lenard A. Adler, Jay D. Amsterdam, et al

Original Research

A Double-Blind, Placebo-Controlled, Crossover Study of Osmotic Release Oral System Methylphenidate in Adults With ADHD With Assessment of Oppositional and Emotional Dimensions of the Disorder

January 15, 2007

Frederick W. Reimherr, Erika D. Williams, Robert E. Strong, et al

Original Research

Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications

January 15, 2007

Cristina Cusin, Maurizio Fava, Jay D. Amsterdam, et al

Original Research

Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 2: Improvement in Psychiatric Measures

December 15, 2003

Dawson W. Hedges, Frederick W. Reimherr, Scott P. Hoopes, et al

Original Research

Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1: Improvement in Binge and Purge Measures

November 15, 2003

Scott P. Hoopes, Frederick W. Reimherr, Dawson W. Hedges, et al

Article

Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression

January 8, 2001

Frederick W. Reimherr, Robert E. Strong, Barrie K. Marchant, et al

Original Research

Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression

July 31, 2000

Patrick J. McGrath, Jonathan W. Stewart, Eva Petkova, et al

Original Research

Changes in Adverse Events Reported by Patients During 6 Months of Fluoxetine Therapy

June 30, 1999

John Zajecka, Jay D. Amsterdam, Frederic M. Quitkin, et al

Types of Adult ADHD

The Effect of Personality Disorder Symptoms on Response to Treatment With Methylphenidate Transdermal System in Adults With Attention-Deficit/Hyperactivity Disorder

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

Gender Differences in 2 Clinical Trials of Adults With Attention-Deficit/Hyperactivity Disorder: A Retrospective Data Analysis

Addition of Atomoxetine for Depression Incompletely Responsive to Sertraline: A Randomized, Double-Blind, Placebo-Controlled Study

A Double-Blind, Placebo-Controlled, Crossover Study of Osmotic Release Oral System Methylphenidate in Adults With ADHD With Assessment of Oppositional and Emotional Dimensions of the Disorder

Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications

Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 2: Improvement in Psychiatric Measures

Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1: Improvement in Binge and Purge Measures

Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression

Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression

Changes in Adverse Events Reported by Patients During 6 Months of Fluoxetine Therapy

ELSEWHERE:

FOLLOW US:

Frederick W. Reimherr, MD

Types of Adult ADHD

The Effect of Personality Disorder Symptoms on Response to Treatment With Methylphenidate Transdermal System in Adults With Attention-Deficit/Hyperactivity Disorder

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

Gender Differences in 2 Clinical Trials of Adults With Attention-Deficit/Hyperactivity Disorder: A Retrospective Data Analysis

Addition of Atomoxetine for Depression Incompletely Responsive to Sertraline: A Randomized, Double-Blind, Placebo-Controlled Study

A Double-Blind, Placebo-Controlled, Crossover Study of Osmotic Release Oral System Methylphenidate in Adults With ADHD With Assessment of Oppositional and Emotional Dimensions of the Disorder

Early Symptomatic Worsening During Treatment With Fluoxetine in Major Depressive Disorder: Prevalence and Implications

Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 2: Improvement in Psychiatric Measures

Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1: Improvement in Binge and Purge Measures

Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression

Predictors of Relapse During Fluoxetine Continuation or Maintenance Treatment of Major Depression

Changes in Adverse Events Reported by Patients During 6 Months of Fluoxetine Therapy

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles